These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16916850)

  • 1. The cholinergic system in Down's syndrome.
    Fodale V; Mafrica F; Caminiti V; Grasso G
    J Intellect Disabil; 2006 Sep; 10(3):261-74. PubMed ID: 16916850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome.
    Lane NJ; Balbo A; Rapoport SI
    Cell Biol Int; 1996 Oct; 20(10):673-80. PubMed ID: 8969460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.
    Contestabile A; Fila T; Bartesaghi R; Contestabile A; Ciani E
    J Neurochem; 2006 Apr; 97(2):515-26. PubMed ID: 16539660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental dissociation of memory systems in mice: behavioral and neurochemical aspects.
    Jaffard R; Durkin T; Toumane A; Marighetto A; Lebrun C
    Arch Gerontol Geriatr Suppl; 1989; 1():55-70. PubMed ID: 2667549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cholinergic function in cell lines derived from the cerebral cortex of normal and trisomy 16 mice.
    Allen DD; Martín J; Arriagada C; Cárdenas AM; Rapoport SI; Caviedes R; Caviedes P
    Eur J Neurosci; 2000 Sep; 12(9):3259-64. PubMed ID: 10998109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Syndrome of partial cholinergic deafferentation of the cortical mantle--a concept for describing the brain-behavior relationship in dementia diseases].
    Arendt T
    Fortschr Neurol Psychiatr; 1991 Mar; 59(3):81-91. PubMed ID: 2050315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic function and dysfunction in the visual system.
    Beelke M; Sannita WG
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():113-7. PubMed ID: 12575477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. People with Down's syndrome can be distinguished on the basis of cholinergic dysfunction.
    Sacks B; Smith S
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1294-5. PubMed ID: 2531786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.
    Galdzicki Z; Siarey RJ
    Genes Brain Behav; 2003 Jun; 2(3):167-78. PubMed ID: 12931790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working memory in the Ts65Dn mouse, a model for Down syndrome.
    Dowdy-Sanders NC; Wenger GR
    Behav Brain Res; 2006 Apr; 168(2):349-52. PubMed ID: 16386318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits and associated neurological complications in individuals with Down's syndrome.
    Lott IT; Dierssen M
    Lancet Neurol; 2010 Jun; 9(6):623-33. PubMed ID: 20494326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down's syndrome: paradox of a tumour repressor.
    Threadgill DW
    Nature; 2008 Jan; 451(7174):21-2. PubMed ID: 18172483
    [No Abstract]   [Full Text] [Related]  

  • 17. The history of the cholinergic hypothesis.
    Contestabile A
    Behav Brain Res; 2011 Aug; 221(2):334-40. PubMed ID: 20060018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic system and depression.
    Dagytė G; Den Boer JA; Trentani A
    Behav Brain Res; 2011 Aug; 221(2):574-82. PubMed ID: 20170685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor metabolic dysfunction in Down's syndrome brains.
    Iulita MF; Do Carmo S; Ower AK; Fortress AM; Flores Aguilar L; Hanna M; Wisniewski T; Granholm AC; Buhusi M; Busciglio J; Cuello AC
    Brain; 2014 Mar; 137(Pt 3):860-72. PubMed ID: 24519975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective retardation of the development of the basal forebrain cholinergic and pontine catecholaminergic nuclei in the brain of trisomy 16 mouse, an animal model of Down's syndrome.
    Kiss J; Schlumpf M; Balázs R
    Brain Res Dev Brain Res; 1989 Dec; 50(2):251-64. PubMed ID: 2575464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.